Meghan Towne is an accomplished professional in the field of genetic diagnostics and clinical genetics with extensive experience in various roles. Currently serving as Associate Director at Ionis Pharmaceuticals, Inc. since October 2025, Meghan has also made significant contributions as a Voting Member on the Institutional Review Board at Mass General Brigham since December 2009. Previously, Meghan worked at Ambry Genetics from March 2016 to September 2025, where responsibilities included conducting educational sessions for healthcare professionals, serving as a Clinical Research Investigator, overseeing clinical research initiatives, and functioning as a Senior Genetic Counselor. Meghan's experience extends to Boston University School of Medicine, where Meghan coordinated research seminar series from June 2013 to May 2022, and at Boston Children's Hospital as a Genetic Counselor from 2009 to March 2016. Educational qualifications include a Master's degree in Genetic Counseling from Boston University School of Medicine and a Bachelor's degree in Biology and Chemistry from Boston College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices